7 completed, 1 active not recruiting, 1 recruiting. 9 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 7, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Vascular Endothelial Growth Factor A: new trials by email Literature Review of Vascular Endothelial Growth Factor A trials Research Report on Vascular Endothelial Growth Factor A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease Liothyronine (L-T3), Bevacizumab, Irinotecan - Medulloblastoma, Medulloblastoma, Childhood | Phase 1 / Phase 2 | Recruiting | Sabine Mueller, MD, PhD | 69 | 2026-08-21 | 2026-09-28 |
| Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection - Age Related Macular Degeneration | Phase 1 / Phase 2 | Completed | Shanghai Henlius Biotech | 20 | 2021-07-15 | 2023-10-23 |
| Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy Vincristine, Dactinomycin, Cyclophosphamide - Rhabdomyosarcoma | Phase 2 | Active not recruiting | St. Jude Children's Research Hospital | 115 | 2013-12-04 | 2026-06-17 |
| Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Bevacizumab - Neurofibromatosis Type 2, Progressive Vestibular Schwannomas | Phase 2 | Completed | University of Alabama at Birmingham | 22 | 2013-05-15 | 2021-02-12 |
| Salvage Ovarian FANG™ Vaccine + Bevacizumab Vigil™ Vaccine, Bevacizumab - Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 2 | Completed | Gradalis, Inc. | 5 | 2012-03-01 | 2021-10-19 |
| North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Sterile saline, Bevacizumab, Estriol - Telangiectasia, Hereditary Hemorrhagic, Epistaxis | Phase 2 | Completed | James Gossage | 123 | 2011-08-01 | 2018-10-19 |
| A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer Bevacizumab, Irinotecan, Capecitabine - Colorectal Cancer | Phase 2 | Completed | University Health Network, Toronto | 50 | 2006-12-01 | 2019-02-15 |
| Bevacizumab in Treating Patients With Angiosarcoma Bevacizumab - Sarcoma | Phase 2 | Completed | Northwestern University | 32 | 2005-10-01 | 2018-06-25 |
| VEGF Gene Transfer for Diabetic Neuropathy VEGF - Diabetic Neuropathy | Phase 1 / Phase 2 | Completed | Losordo, Douglas, M.D. | 60 | 2002-12-01 | 2010-11-11 |
Carcinoma, Ovarian Epithelial (1) · Colorectal Neoplasms (1) · Diabetes Mellitus (1) · Diabetic Neuropathies (1) · Epistaxis (1) · Hemangiosarcoma (1) · Macular Degeneration (1) · Medulloblastoma (1) · Neoplasm Metastasis (1) · Neurofibromatosis 2 (1) · Ovarian Neoplasms (1) · Peripheral Arterial Disease (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Telangiectasia, Hereditary Hemorrhagic (1)
Gradalis, Inc. (1) · James Gossage (1) · Losordo, Douglas, M.D. (1) · Northwestern University (1) · Sabine Mueller, MD, PhD (1) · Shanghai Henlius Biotech (1) · St. Jude Children's Research Hospital (1) · University Health Network, Toronto (1) · University of Alabama at Birmingham (1)
United States (7) · Canada (1) · China (1)
Allan H Ropper, M.D. (1) · Eric Chen (1) · James R Gossage, MD (1) · Mark Agulnik, MD (1) · Matthew J. Krasin, MD (1) · Minal Barve, MD (1) · Sabine Mueller (1) · Scott Plotkin, MD (1)